Cervical Cancer News
Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading
HPV Vaccine Protects Against Genital Warts and Precancerous Growths (July 30, 2010)Results from a recent international study indicate that the vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) protects against genital warts and low-grade precancerous changes to the cervix, vulva, and vagina.... Continue Reading
Many Physicians Fail to Adhere to New Cervical Cancer Screening Guidelines (July 12, 2010)Apparently, old habits die hard: less than one-third of physicians report compliance with the updated guidelines for cervical cancer screening that suggest longer intervals between screening for women with normal test results. The results of this survey... Continue Reading
More Than Half of Young Adults in New Relationships Infected with HPV (April 26, 2010)More than half of young adults in a new sexual relationship are infected with human papillomavirus (HPV), and of those 44% were infected with an HPV type that causes cancer, according to the results of a groundbreaking study called the HITCH Cohort... Continue Reading
Cervical Vaccine Provides Little Benefit for Older Women (March 4, 2010)Women over the age of 40 are not likely to benefit from a vaccine designed to prevent human papillomavirus (HPV), according to the results of a study published in the Journal of the National Cancer Institute.1 HPV has been shown to cause cervical cancer. Human... Continue Reading
Cervarix® Protection Extends Beyond Six Years (February 12, 2010)Cervarix®—a vaccine that reduces the risk of cervical cancer by protecting against two high-risk types of human papillomavirus (HPV)—remains effective for more than six years. These results were published in the Lancet. Human papillomaviruses... Continue Reading
ACOG Updates Cervical Cancer Screening Guidelines (November 20, 2009)The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These... Continue Reading
Second HPV Vaccine Approved in U.S. (October 16, 2009)The U.S. Food and Drug Administration has approved Cervarix®, a vaccine against two high-risk types of human papillomavirus (HPV), for prevention of cervical cancer and cervical precancers. This is the second HPV vaccine to be approved in the United... Continue Reading
Number of Obesity-related Cancers Is Growing (October 3, 2009)In 2008, excess body weight was responsible for over 124,000 new cancer diagnoses in Europe. These results were presented at a major European cancer conference. Obesity is increasingly being recognized as a risk factor not only for cancer development,... Continue Reading
FDA Advisory Committee Backs Second Cervical Cancer Vaccine (September 11, 2009)A U.S. Food and Drug Administration (FDA) advisory committee has concluded that Cervarix®—a vaccine against two high-risk types of human papillomavirus (HPV)—is safe and effective for the prevention of cervical cancer. Human papillomaviruses consist... Continue Reading
Latest Cervical Cancer News By Stage
Metastatic/Stage IVB Cervical Cancer
January Is National Cervical Cancer Awareness Month (March 8, 2009)
January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
Updates in the Management of Gynecologic Cancers (May 27, 2008)Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading
More Metastatic/Stage IVB Cervical CancerRecurrent Cervical Cancer
January Is National Cervical Cancer Awareness Month (March 8, 2009)
January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
Avastin® Shows Promise in Treatment of Cervical Cancer (March 8, 2009)Avastin® Shows Promise in Treatment of Cervical Cancer According to the results of a Phase II clinical trial, the targeted therapy Avastin® (bevacizumab) warrants further investigation in the treatment of persistent or recurrent squamous cell carcinoma... Continue Reading
Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (March 8, 2009)Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective... Continue Reading
More Recurrent Cervical CancerScreening/Prevention Cervical Cancer
HPV Vaccine Protects Against Genital Warts and Precancerous Growths (July 30, 2010)
Results from a recent international study indicate that the vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) protects against genital warts and low-grade precancerous changes to the cervix, vulva, and vagina.... Continue Reading
Many Physicians Fail to Adhere to New Cervical Cancer Screening Guidelines (July 12, 2010)Apparently, old habits die hard: less than one-third of physicians report compliance with the updated guidelines for cervical cancer screening that suggest longer intervals between screening for women with normal test results. The results of this survey... Continue Reading
More Than Half of Young Adults in New Relationships Infected with HPV (April 26, 2010)More than half of young adults in a new sexual relationship are infected with human papillomavirus (HPV), and of those 44% were infected with an HPV type that causes cancer, according to the results of a groundbreaking study called the HITCH Cohort... Continue Reading
Cervical Vaccine Provides Little Benefit for Older Women (March 4, 2010)Women over the age of 40 are not likely to benefit from a vaccine designed to prevent human papillomavirus (HPV), according to the results of a study published in the Journal of the National Cancer Institute.1 HPV has been shown to cause cervical cancer. Human... Continue Reading
Cervarix® Protection Extends Beyond Six Years (February 12, 2010)Cervarix®—a vaccine that reduces the risk of cervical cancer by protecting against two high-risk types of human papillomavirus (HPV)—remains effective for more than six years. These results were published in the Lancet. Human papillomaviruses... Continue Reading
More Screening/Prevention Cervical CancerStage I Cervical Cancer
Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer (June 9, 2009)
Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer The majority of women with cervical cancer can safely undergo sentinel node biopsy instead of full pelvic lymph node dissection to determine the spread... Continue Reading
January Is National Cervical Cancer Awareness Month (March 8, 2009)January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading
Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading
Updates in the Management of Gynecologic Cancers (May 27, 2008)Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading
More Stage I Cervical CancerStages II-IVA Cervical Cancer
Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)
A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading
Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer (June 8, 2009)Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer The combination of Gemzar® (gemcitabine), Platinol® (cisplatin), and concurrent radiation significantly improves survival over single-agent Platinol and radiation... Continue Reading
January Is National Cervical Cancer Awareness Month (March 8, 2009)January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading
Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading
More Stages II-IVA Cervical Cancer